Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

A multicenter study of the real-world use of ceftaroline versus vancomycin for acute bacterial skin and skin structure infections.

Trinh TD, Jorgensen SCJ, Zasowski EJ, Claeys KC, Lagnf AM, Estrada SJ, Delaportes DJ, Huang V, Klinker KP, Kaye KS, Davis SL, Rybak MJ.

Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.01007-19. doi: 10.1128/AAC.01007-19. [Epub ahead of print]

PMID:
31405859
2.

Daptomycin plus beta-lactam combination therapy for methicillin-resistant Staphylococcus aureus bloodstream infections: a retrospective, comparative cohort study.

Jorgensen SCJ, Zasowski EJ, Trinh TD, Lagnf AM, Bhatia S, Sabagha N, Abdul-Mutakabbir JC, Alosaimy S, Mynatt RP, Davis SL, Rybak MJ.

Clin Infect Dis. 2019 Aug 12. pii: ciz746. doi: 10.1093/cid/ciz746. [Epub ahead of print]

PMID:
31404468
3.

Diagnostic Stewardship: A Clinical Decision Rule for Blood Cultures in Community-Onset Methicillin-Resistant Staphylococcus aureus (MRSA) Skin and Soft Tissue Infections.

Jorgensen SCJ, Lagnf AM, Bhatia S, Singh NB, Shammout LK, Davis SL, Rybak MJ.

Infect Dis Ther. 2019 Jun;8(2):229-242. doi: 10.1007/s40121-019-0238-1. Epub 2019 Feb 19.

4.

A new simplified predictive model for mortality in methicillin-resistant Staphylococcus aureus bacteremia.

Jorgensen SCJ, Lagnf AM, Bhatia S, Rybak MJ.

Eur J Clin Microbiol Infect Dis. 2019 May;38(5):843-850. doi: 10.1007/s10096-018-03464-0. Epub 2019 Feb 8.

PMID:
30734879
5.

Risk Factors for Bloodstream Infections Among an Urban Population with Skin and Soft Tissue Infections: A Retrospective Unmatched Case-Control Study.

Rybak MJ, Zasowski EJ, Jorgensen SCJ, Lagnf AM, Davis SL, Mendelsohn AB, Margaritis V.

Infect Dis Ther. 2019 Mar;8(1):75-85. doi: 10.1007/s40121-018-0227-9. Epub 2018 Dec 18.

6.

Sequential intravenous-to-oral outpatient antibiotic therapy for MRSA bacteraemia: one step closer.

Jorgensen SCJ, Lagnf AM, Bhatia S, Shamim MD, Rybak MJ.

J Antimicrob Chemother. 2019 Feb 1;74(2):489-498. doi: 10.1093/jac/dky452.

PMID:
30418557
7.

Development of a Risk-Scoring Tool to Determine Appropriate Level of Care in Acute Bacterial Skin and Skin Structure Infections in an Acute Healthcare Setting.

Claeys KC, Zasowski EJ, Lagnf AM, Sabagha N, Levine DP, Davis SL, Rybak MJ.

Infect Dis Ther. 2018 Dec;7(4):495-507. doi: 10.1007/s40121-018-0212-3. Epub 2018 Sep 22.

8.

Antimicrobial Stewardship Opportunities in Critically Ill Patients with Gram-Negative Lower Respiratory Tract Infections: A Multicenter Cross-Sectional Analysis.

Claeys KC, Zasowski EJ, Trinh TD, Lagnf AM, Davis SL, Rybak MJ.

Infect Dis Ther. 2018 Mar;7(1):135-146. doi: 10.1007/s40121-017-0179-5. Epub 2017 Nov 21.

9.

Multidrug-resistant Pseudomonas aeruginosa lower respiratory tract infections in the intensive care unit: Prevalence and risk factors.

Trinh TD, Zasowski EJ, Claeys KC, Lagnf AM, Kidambi S, Davis SL, Rybak MJ.

Diagn Microbiol Infect Dis. 2017 Sep;89(1):61-66. doi: 10.1016/j.diagmicrobio.2017.06.009. Epub 2017 Jun 19.

PMID:
28716451
10.

Novel application of published risk factors for methicillin-resistant S. aureus in acute bacterial skin and skin structure infections.

Claeys KC, Zasowski EJ, Lagnf AM, Levine DP, Davis SL, Rybak MJ.

Int J Antimicrob Agents. 2018 Jan;51(1):43-46. doi: 10.1016/j.ijantimicag.2017.05.015. Epub 2017 Jun 28.

PMID:
28668679
11.

Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.

Zasowski EJ, Trinh TD, Claeys KC, Casapao AM, Sabagha N, Lagnf AM, Klinker KP, Davis SL, Rybak MJ.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e02015-16. doi: 10.1128/AAC.02015-16. Print 2017 Feb.

12.

Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.

Claeys KC, Zasowski EJ, Casapao AM, Lagnf AM, Nagel JL, Nguyen CT, Hallesy JA, Compton MT, Kaye KS, Levine DP, Davis SL, Rybak MJ.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):5841-8. doi: 10.1128/AAC.00227-16. Print 2016 Oct.

13.

Comparison of clinical outcomes and risk factors in polymicrobial versus monomicrobial enterococcal bloodstream infections.

Lagnf AM, Zasowski EJ, Claeys KC, Casapao AM, Rybak MJ.

Am J Infect Control. 2016 Aug 1;44(8):917-21. doi: 10.1016/j.ajic.2016.02.017. Epub 2016 Apr 11.

PMID:
27079241
14.

Time Is of the Essence: The Impact of Delayed Antibiotic Therapy on Patient Outcomes in Hospital-Onset Enterococcal Bloodstream Infections.

Zasowski EJ, Claeys KC, Lagnf AM, Davis SL, Rybak MJ.

Clin Infect Dis. 2016 May 15;62(10):1242-1250. doi: 10.1093/cid/ciw110. Epub 2016 Mar 3.

15.

Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus: Does Vancomycin Heteroresistance Matter?

Claeys KC, Lagnf AM, Hallesy JA, Compton MT, Gravelin AL, Davis SL, Rybak MJ.

Antimicrob Agents Chemother. 2016 Jan 4;60(3):1708-16. doi: 10.1128/AAC.02388-15.

16.

Comparison of outcomes between patients with single versus multiple positive blood cultures for Enterococcus: Infection versus illusion?

Claeys KC, Zasowski EJ, Lagnf AM, Rybak MJ.

Am J Infect Control. 2016 Jan 1;44(1):47-9. doi: 10.1016/j.ajic.2015.08.002. Epub 2015 Sep 19.

PMID:
26388037
17.

Acute Bacterial Skin and Skin Structure Infections Treated with Intravenous Antibiotics in the Emergency Department or Observational Unit: Experience at the Detroit Medical Center.

Claeys KC, Lagnf AM, Patel TB, Jacob MG, Davis SL, Rybak MJ.

Infect Dis Ther. 2015 Jun;4(2):173-86. doi: 10.1007/s40121-015-0069-7. Epub 2015 Jun 9.

18.

Evaluation of vancomycin population susceptibility analysis profile as a predictor of outcomes for patients with infective endocarditis due to methicillin-resistant Staphylococcus aureus.

Casapao AM, Davis SL, McRoberts JP, Lagnf AM, Patel S, Kullar R, Levine DP, Rybak MJ.

Antimicrob Agents Chemother. 2014 Aug;58(8):4636-41. doi: 10.1128/AAC.02820-13. Epub 2014 Jun 2.

Supplemental Content

Loading ...
Support Center